A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors-Reference-Cited by-同舟云学术

A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors

Published:2010-05-12 Issue:5 Volume:29 Page:1004-1012
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Dickson Mark Andrew,Rathkopf Dana E.,Carvajal Richard D.,Grant Steven,Roberts John D.,Reid Joel M.,Ames Matthew M.,McGovern Renee M.,Lefkowitz Robert A.,Gonen Mithat,Cane Lauren M.,Dials Heather J.,Schwartz Gary K.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-010-9447-x.pdf

Reference39 articles.

1. Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389:349–352

2. Johnstone RW (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 1:287–299

3. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK (2001) Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1:194–202

4. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428

5. Arts J, de Schepper S, Van Emelen K (2003) Histone deacetylase inhibitors: from chromatin remodeling to experimental cancer therapeutics. Curr Med Chem 10:2343–2350

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model;International Journal of Molecular Sciences;2023-02-14

2. Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas;Biochemical Pharmacology;2022-04

3. CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug Modulation;Journal of Medicinal Chemistry;2022-03-29

4. CRCM5484: A BET-BDII Selective Compound With Differential Anti-Leukemic Drug Potentiation;2021-12-14

5. Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter;Cell Chemical Biology;2021-09